Scout Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $36.3M | Sell |
533,289
-247,368
| -32% | -$18M | 0.96% | 24 |
|
|
2024
Q2 | $72.1M | Buy |
+780,657
| New | +$69.1M | 1.94% | 2 |
|
|
2023
Q3 | – | Sell |
-1,130,381
| Closed | -$104M | – | 222 |
|
|
2023
Q2 | $104M | Buy |
1,130,381
+375,775
| +50% | +$32.7M | 2.11% | 3 |
|
|
2023
Q1 | $62.4M | Buy |
+754,606
| New | +$59.3M | 1.27% | 11 |
|
|
2022
Q3 | – | Sell |
-101,398
| Closed | -$9.64M | – | 227 |
|
|
2022
Q2 | $9.64M | Buy |
101,398
+74,763
| +281% | +$7.74M | 0.19% | 134 |
|
|
2022
Q1 | $3.13M | Sell |
26,635
-81,957
| -75% | -$9.19M | 0.05% | 220 |
|
|
2021
Q4 | $14.1M | Sell |
108,592
-1,443
| -1% | -$168K | 0.2% | 143 |
|
|
2021
Q3 | $12.5M | Sell |
110,035
-56,918
| -34% | -$6.5M | 0.19% | 167 |
|
|
2021
Q2 | $17.3M | Sell |
166,953
-118,072
| -41% | -$11.1M | 0.26% | 127 |
|
|
2021
Q1 | $23.8M | Buy |
285,025
+31,928
| +13% | +$2.7M | 0.36% | 104 |
|
|
2020
Q4 | $23.1M | Sell |
253,097
-28,098
| -10% | -$2.33M | 0.42% | 83 |
|
|
2020
Q3 | $22.4M | Sell |
281,195
-16,480
| -6% | -$1.29M | 0.5% | 66 |
|
|
2020
Q2 | $20.6M | Sell |
297,675
-8,040
| -3% | -$571K | 0.49% | 69 |
|
|
2020
Q1 | $19.2M | Sell |
305,715
-63,771
| -17% | -$4.6M | 0.57% | 61 |
|
|
2019
Q4 | $28.7M | Buy |
369,486
+85,710
| +30% | +$6.69M | 0.56% | 65 |
|
|
2019
Q3 | $20.8M | Sell |
283,776
-8,277
| -3% | -$581K | 0.41% | 84 |
|
|
2019
Q2 | $18M | Sell |
292,053
-78,888
| -21% | -$4.77M | 0.35% | 100 |
|
|
2019
Q1 | $23.7M | Buy |
370,941
+189,219
| +104% | +$10.8M | 0.48% | 66 |
|
|
2018
Q4 | $9.28M | Sell |
181,722
-554,970
| -75% | -$28.1M | 0.23% | 127 |
|
|
2018
Q3 | $42.8M | Buy |
736,692
+306,642
| +71% | +$15M | 0.88% | 13 |
|
|
2018
Q2 | $20.9M | Sell |
430,050
-88,128
| -17% | -$4.11M | 0.47% | 80 |
|
|
2018
Q1 | $24.1M | Sell |
518,178
-49,782
| -9% | -$2.16M | 0.58% | 46 |
|
|
2017
Q4 | $21.3M | Sell |
567,960
-121,605
| -18% | -$4.46M | 0.53% | 69 |
|
|
2017
Q3 | $25.1M | Buy |
689,565
+6,381
| +0.9% | +$243K | 0.69% | 40 |
|
|
2017
Q2 | $26.9M | Buy |
683,184
+192,573
| +39% | +$7.03M | 0.78% | 22 |
|
|
2017
Q1 | $15.4M | Sell |
490,611
-71,475
| -13% | -$2.24M | 0.42% | 112 |
|
|
2016
Q4 | $17.6M | Sell |
562,086
-538,815
| -49% | -$17.5M | 0.49% | 83 |
|
|
2016
Q3 | $44.2M | Buy |
1,100,901
+322,941
| +42% | +$12.2M | 1.24% | 8 |
|
|
2016
Q2 | $25.9M | Buy |
777,960
+334,410
| +75% | +$11.4M | 0.72% | 41 |
|
|
2016
Q1 | $13M | Sell |
443,550
-393,579
| -47% | -$10.9M | 0.36% | 106 |
|
|
2015
Q4 | $22M | Sell |
837,129
-340,611
| -29% | -$8.85M | 0.55% | 68 |
|
|
2015
Q3 | $27.9M | Buy |
1,177,740
+17,748
| +2% | +$428K | 0.65% | 56 |
|
|
2015
Q2 | $27.5M | Sell |
1,159,992
-75,150
| -6% | -$1.7M | 0.51% | 62 |
|
|
2015
Q1 | $29.3M | Buy |
+1,235,142
| New | +$27.7M | 0.49% | 80 |
|
Other funds holding EW
Scout Investments's EW Position: Q3 2024 in Review
Scout Investments reduced its Edwards Lifesciences (EW) stake by 32% in Q3 2024, selling an estimated $18M and leaving 533,289 shares worth $36.3M. The position accounts for 0.96% of the portfolio, ranked #24.
Scout Investments first reported a position in EW in Q1 2015 and has held it in 34 quarters since. The position peaked at $104M in Q2 2023. 1,193 funds tracked by Wall St. Rank hold EW as of Q3 2024.
- Scout Investments held 533,289 shares of Edwards Lifesciences worth $36.3M as of Q3 2024.
- Scout Investments sold 247,368 Edwards Lifesciences shares in Q3 2024, an estimated $18M.
- Edwards Lifesciences made up 0.96% of Scout Investments's portfolio in Q3 2024, its #24 holding.
- Scout Investments first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 34 quarters since.
- Scout Investments's Edwards Lifesciences position peaked at $104M in Q2 2023.
- 1,193 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.
Based on Scout Investments's 13F filing for Q3 2024, filed 12 Nov 2024.